SK10552002A3 - Kombinácia a jej použitie - Google Patents
Kombinácia a jej použitie Download PDFInfo
- Publication number
- SK10552002A3 SK10552002A3 SK1055-2002A SK10552002A SK10552002A3 SK 10552002 A3 SK10552002 A3 SK 10552002A3 SK 10552002 A SK10552002 A SK 10552002A SK 10552002 A3 SK10552002 A3 SK 10552002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- mirtazapine
- gepirone
- combination
- treatment
- depression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00200189 | 2000-01-19 | ||
PCT/EP2001/000407 WO2001052855A2 (en) | 2000-01-19 | 2001-01-15 | Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
Publications (1)
Publication Number | Publication Date |
---|---|
SK10552002A3 true SK10552002A3 (sk) | 2002-12-03 |
Family
ID=8170928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1055-2002A SK10552002A3 (sk) | 2000-01-19 | 2001-01-15 | Kombinácia a jej použitie |
Country Status (21)
Country | Link |
---|---|
US (2) | US6835728B2 (xx) |
EP (1) | EP1251854A2 (xx) |
JP (1) | JP2003520237A (xx) |
KR (1) | KR20020068404A (xx) |
CN (1) | CN1223349C (xx) |
AR (1) | AR027240A1 (xx) |
AU (1) | AU780817B2 (xx) |
BR (1) | BR0107721A (xx) |
CA (1) | CA2396066A1 (xx) |
CO (1) | CO5261583A1 (xx) |
HK (1) | HK1047548A1 (xx) |
HU (1) | HUP0204050A3 (xx) |
IL (1) | IL150289A0 (xx) |
MX (1) | MXPA02007095A (xx) |
NO (1) | NO20023448L (xx) |
PE (1) | PE20011049A1 (xx) |
PL (1) | PL356605A1 (xx) |
RU (1) | RU2268725C2 (xx) |
SK (1) | SK10552002A3 (xx) |
WO (1) | WO2001052855A2 (xx) |
ZA (1) | ZA200205161B (xx) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
AR033485A1 (es) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma |
US20060039866A1 (en) * | 2004-08-20 | 2006-02-23 | Cypress Bioscience, Inc. | Method for treating sleep-related breathing disorders |
US20060122127A1 (en) * | 2004-11-17 | 2006-06-08 | Cypress Bioscience, Inc. | Methods for reducing the side effects associated with mirtzapine treatment |
TW200800306A (en) | 2005-09-12 | 2008-01-01 | Wyeth Corp | Sustained-release formulation and uses thereof |
GT200600416A (es) | 2005-09-12 | 2007-09-20 | Sales salicilato y gentisato de un compuesto de piperazina | |
GT200600414A (es) | 2005-09-12 | 2007-09-20 | Sal de glucuranato de compuesto de piperazine | |
EP1792618A1 (en) * | 2005-11-30 | 2007-06-06 | Rainer Freynhagen | R-mirtazapine for the treatment of pain |
TW200808804A (en) * | 2006-05-22 | 2008-02-16 | Organon Nv | Mirtazapine for the treatment of neuropathic pain |
MX2008014840A (es) * | 2006-05-22 | 2008-12-05 | Vanda Pharmaceuticals Inc | Tratamiento de trastornos depresivos. |
EP2167096A4 (en) * | 2007-06-13 | 2010-07-14 | Cypress Bioscience Inc | IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM |
CA2704117C (en) * | 2007-11-02 | 2015-11-17 | Acrux Dds Pty Ltd | Transdermal delivery system |
CN102918031A (zh) | 2010-05-28 | 2013-02-06 | 通用电气健康护理有限公司 | 放射标记的化合物及其方法 |
GB201112987D0 (en) | 2011-07-28 | 2011-09-14 | Ge Healthcare Ltd | Novel compound |
CN108743593B (zh) * | 2018-08-31 | 2019-03-26 | 程世宏 | 一种抗抑郁药物及其口服颗粒剂和制药用途 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
US4771053A (en) * | 1987-03-02 | 1988-09-13 | Bristol-Myers Company | Method for alleviation of primary depressive disorders |
US5114976A (en) * | 1989-01-06 | 1992-05-19 | Norden Michael J | Method for treating certain psychiatric disorders and certain psychiatric symptoms |
US5011841B1 (en) * | 1989-11-14 | 1994-09-06 | Pfizer | Treatment of depression |
GB9303968D0 (en) * | 1993-02-26 | 1993-04-14 | Wyeth John & Brother Ltd | 5-ht1a ligands |
GB9603136D0 (en) * | 1996-02-15 | 1996-04-17 | Merck Sharp & Dohme | Therapeutic agents |
IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
ZA982368B (en) * | 1997-03-27 | 1998-09-23 | Akzo Nobel Nv | New therapeutic combinations |
IL123716A (en) * | 1997-03-27 | 2001-03-19 | Akzo Nobel Nv | Therapeutic combinations of mirtazapine and an antipsychotic agent |
-
2001
- 2001-01-15 HU HU0204050A patent/HUP0204050A3/hu unknown
- 2001-01-15 EP EP01900449A patent/EP1251854A2/en not_active Withdrawn
- 2001-01-15 US US10/181,843 patent/US6835728B2/en not_active Expired - Fee Related
- 2001-01-15 AU AU25162/01A patent/AU780817B2/en not_active Ceased
- 2001-01-15 BR BR0107721-0A patent/BR0107721A/pt not_active IP Right Cessation
- 2001-01-15 KR KR1020027009276A patent/KR20020068404A/ko not_active Application Discontinuation
- 2001-01-15 CN CNB018038654A patent/CN1223349C/zh not_active Expired - Fee Related
- 2001-01-15 PL PL01356605A patent/PL356605A1/xx not_active Application Discontinuation
- 2001-01-15 MX MXPA02007095A patent/MXPA02007095A/es not_active Application Discontinuation
- 2001-01-15 SK SK1055-2002A patent/SK10552002A3/sk not_active Application Discontinuation
- 2001-01-15 JP JP2001552902A patent/JP2003520237A/ja not_active Withdrawn
- 2001-01-15 WO PCT/EP2001/000407 patent/WO2001052855A2/en not_active Application Discontinuation
- 2001-01-15 RU RU2002122084/15A patent/RU2268725C2/ru not_active IP Right Cessation
- 2001-01-15 IL IL15028901A patent/IL150289A0/xx unknown
- 2001-01-15 CA CA002396066A patent/CA2396066A1/en not_active Abandoned
- 2001-01-18 AR ARP010100214A patent/AR027240A1/es not_active Application Discontinuation
- 2001-01-18 PE PE2001000055A patent/PE20011049A1/es not_active Application Discontinuation
- 2001-01-18 CO CO01003479A patent/CO5261583A1/es not_active Application Discontinuation
-
2002
- 2002-06-27 ZA ZA200205161A patent/ZA200205161B/en unknown
- 2002-07-18 NO NO20023448A patent/NO20023448L/no not_active Application Discontinuation
- 2002-12-18 HK HK02109168.5A patent/HK1047548A1/zh unknown
-
2004
- 2004-11-22 US US10/996,213 patent/US20050090488A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1251854A2 (en) | 2002-10-30 |
CN1395486A (zh) | 2003-02-05 |
BR0107721A (pt) | 2002-10-01 |
AU2516201A (en) | 2001-07-31 |
NO20023448L (no) | 2002-09-17 |
HK1047548A1 (zh) | 2003-02-28 |
AR027240A1 (es) | 2003-03-19 |
WO2001052855A8 (en) | 2002-12-27 |
MXPA02007095A (es) | 2003-04-14 |
RU2268725C2 (ru) | 2006-01-27 |
PE20011049A1 (es) | 2001-10-18 |
CO5261583A1 (es) | 2003-03-31 |
RU2002122084A (ru) | 2004-03-10 |
JP2003520237A (ja) | 2003-07-02 |
PL356605A1 (en) | 2004-06-28 |
US20050090488A1 (en) | 2005-04-28 |
AU780817B2 (en) | 2005-04-21 |
US20030105083A1 (en) | 2003-06-05 |
US6835728B2 (en) | 2004-12-28 |
HUP0204050A3 (en) | 2004-09-28 |
WO2001052855A3 (en) | 2002-01-10 |
CA2396066A1 (en) | 2001-07-26 |
HUP0204050A2 (hu) | 2003-03-28 |
IL150289A0 (en) | 2002-12-01 |
ZA200205161B (en) | 2003-09-29 |
WO2001052855A2 (en) | 2001-07-26 |
NO20023448D0 (no) | 2002-07-18 |
CN1223349C (zh) | 2005-10-19 |
KR20020068404A (ko) | 2002-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4249415B2 (ja) | Cns疾患の治療のためのピロリジンアセトアミド誘導体単体又は組み合わせ物 | |
US20050096311A1 (en) | Compositions and methods for treatment of nervous system disorders | |
EP1994932A1 (en) | Use of N-desmethylclozapine to treat human psychosis | |
US20080214592A1 (en) | Methods of treating anxiety disorders | |
US20060122127A1 (en) | Methods for reducing the side effects associated with mirtzapine treatment | |
SK10552002A3 (sk) | Kombinácia a jej použitie | |
CA2500662A1 (en) | Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders | |
US9732059B2 (en) | Methods of use of cyclic amide derivatives to treat schizophrenia | |
US20080004284A1 (en) | Method for treating fibromyalgia syndrome and related conditions | |
KR100425045B1 (ko) | 약물중독의치료를위한멜라토닌함유약학적조성물 | |
WO1993021917A1 (en) | Dopamine and noradrenergic reuptake inhibitors in treatment of schizophrenia | |
US20180155318A1 (en) | Methods of use of cyclic amide derivatives to treat schizophrenia | |
KR20100038120A (ko) | 신경퇴행성 장애의 치료를 위한 신규한 네라멕산 조합물 | |
SK284521B6 (sk) | Použitie melatonínu na prípravu farmaceutického prostriedku | |
US6979698B1 (en) | Method of treating cognitive deficits in learning and memory | |
Goldberg | Sustained yawning as a side effect of imipramine | |
CN101028265A (zh) | 一种改善睡眠调整睡醒节律的黑白药物组合物 | |
WO2005097138A2 (en) | Combinations comprising oxcarbazepine to treat affective disorders | |
CZ20022320A3 (cs) | Kombinace účinných látek a její použití pro výrobu farmaceutického prostředku | |
CN1931153A (zh) | 用于治疗抑郁症及相关病症的包括文拉法辛的药物组合物 | |
Lahmeyer | Pharmacology of sleep | |
WO2002016347A1 (en) | Active metabolite of gepirone | |
Lindsey | Effects of monoamine transporter blockers on cocaine self-administration: Relation to dopamine transporter occupancy measured by PET in rhesus monkeys. An investigation of substitute agonist therapeutic strategies for cocaine addiction | |
MXPA97005856A (en) | Use of melatonine in the manufacture of unmedicament to deal with addiction to dro |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC9A | Refused patent application |